Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy

Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy

Gynecological tumors are malignancies with both high morbidity and mortality. To date, only a few chemotherapeutic agents have shown efficacy against these cancer types (only ovarian cancer responds to several agents, especially platinum-based combinations). Within this context, the discovery of imm...

Full description

Bibliographic Details
Main Authors: Giuseppe Schepisi, Chiara Casadei, Ilaria Toma, Giulia Poti, Maria Laura Iaia, Alberto Farolfi, Vincenza Conteduca, Cristian Lolli, Giorgia Ravaglia, Nicole Brighi, Amelia Altavilla, Giovanni Martinelli, Ugo De Giorgi
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
chimeric antigen receptor (CAR)-T cell therapy
lymphocytes
immunotherapy
ovarian cancer
endometrial cancer
cervical cancer
Online Access:https://www.mdpi.com/2072-6694/13/4/840

Internet

https://www.mdpi.com/2072-6694/13/4/840

Similar Items